SUMOylation in Viral Replication and Antiviral Defense

Overview

Journal Adv Sci (Weinh)

Specialty Biomedical Engineering

Date 2022 Jan 21

PMID 35060688

Authors

Yao Fan

Xiang Li

Lei Zhang

Zhi Zong

Fangwei Wang

Jun Huang

Linghui Zeng

Chong Zhang

Haiyan Yan

Long Zhang

Fangfang Zhou

Affiliations

Soon will be listed here.

Abstract

SUMOylation is a ubiquitination-like post-translational modification that plays an essential role in the regulation of protein function. Recent studies have shown that proteins from both RNA and DNA virus families can be modified by SUMO conjugation, which facilitates viral replication. Viruses can manipulate the entire process of SUMOylation through interplay with the SUMO pathway. By contrast, SUMOylation can eliminate viral infection by regulating host antiviral immune components. A deeper understanding of how SUMOylation regulates viral proteins and cellular antiviral components is necessary for the development of effective antiviral therapies. In the present review, the regulatory mechanism of SUMOylation in viral replication and infection and the antiviral immune response, and the consequences of this regulation for viral replication and engagement with antiviral innate immunity are summarized. The potential therapeutic applications of SUMOylation in diseases caused by viruses are also discussed.

Citing Articles

Ubiquitin and ubiquitin-like proteins in HPV-driven carcinogenesis.

Wootton L, Morgan E Oncogene. 2025; 44(11):713-723.

PMID: 40011575 PMC: 11888991. DOI: 10.1038/s41388-025-03310-6.

SUMOylated GLUT1 inhibited the glycometabolism disorder in chondroctyes during osteoarthritis.

Xiong L Glycoconj J. 2025; 42(1):41-52.

PMID: 39797965 DOI: 10.1007/s10719-024-10176-5.

E2 Ubiquitin-Conjugating Enzymes Regulates Dengue Virus-2 Replication in .

Wang J, Zheng X, Wang X, Zhong D, Zhou G Microorganisms. 2025; 12(12.

PMID: 39770712 PMC: 11676440. DOI: 10.3390/microorganisms12122508.

Human ANP32A/B are SUMOylated and utilized by avian influenza virus NS2 protein to overcome species-specific restriction.

Sun L, Guo X, Yu M, Wang X, Ren H, Wang X Nat Commun. 2024; 15(1):10805.

PMID: 39737943 PMC: 11686252. DOI: 10.1038/s41467-024-55034-y.

RNF4 mediated degradation of PDHA1 promotes colorectal cancer metabolism and metastasis.

Chen J, Li Z, Zheng G, Cao L, Guo Y, Lian Q NPJ Precis Oncol. 2024; 8(1):258.

PMID: 39521913 PMC: 11550450. DOI: 10.1038/s41698-024-00724-5.

References

Liu X, Chen W, Wang Q, Li L, Wang C . Negative regulation of TLR inflammatory signaling by the SUMO-deconjugating enzyme SENP6. PLoS Pathog. 2013; 9(6):e1003480. PMC: 3694847. DOI: 10.1371/journal.ppat.1003480. View

El-Asmi F, McManus F, Thibault P, Chelbi-Alix M . Interferon, restriction factors and SUMO pathways. Cytokine Growth Factor Rev. 2020; 55:37-47. DOI: 10.1016/j.cytogfr.2020.03.001. View

Bohl C, Abrahamyan L, Wood C . Human Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner. PLoS One. 2013; 8(7):e69359. PMC: 3704627. DOI: 10.1371/journal.pone.0069359. View

Tatham M, Kim S, Jaffray E, Song J, Chen Y, Hay R . Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat Struct Mol Biol. 2004; 12(1):67-74. DOI: 10.1038/nsmb878. View

Choi G, Lee Y, Yun M, Kang J, Lee S . Formation of SUMO3-conjugated chains of MAVS induced by poly(dA:dT), a ligand of RIG-I, enhances the aggregation of MAVS that drives the secretion of interferon-β in human keratinocytes. Biochem Biophys Res Commun. 2019; 522(4):939-944. DOI: 10.1016/j.bbrc.2019.11.189. View

Lusic M, Marini B, Ali H, Lucic B, Luzzati R, Giacca M . Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells. Cell Host Microbe. 2013; 13(6):665-77. DOI: 10.1016/j.chom.2013.05.006. View

Liu Q, Zhou B, Liao R, Zhou X, Yan X . PIAS4, upregulated in hepatocellular carcinoma, promotes tumorigenicity and metastasis. J Cell Biochem. 2020; 121(5-6):3372-3381. DOI: 10.1002/jcb.29610. View

Yan N, Chen Z . Intrinsic antiviral immunity. Nat Immunol. 2012; 13(3):214-22. PMC: 3549670. DOI: 10.1038/ni.2229. View

Xi R, Kadur Lakshminarasimha Murthy P, Tung K, Guy C, Wan J, Li F . SENP3-mediated host defense response contains HBV replication and restores protein synthesis. PLoS One. 2019; 14(1):e0209179. PMC: 6331149. DOI: 10.1371/journal.pone.0209179. View

10.

Boggio R, Passafaro A, Chiocca S . Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation. J Biol Chem. 2007; 282(21):15376-82. DOI: 10.1074/jbc.M700889200. View

11.

Ferguson B, Mansur D, Peters N, Ren H, Smith G . DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife. 2012; 1:e00047. PMC: 3524801. DOI: 10.7554/eLife.00047. View

12.

Turci M, Lodewick J, Di Gennaro G, Rinaldi A, Marin O, Diani E . Ubiquitination and sumoylation of the HTLV-2 Tax-2B protein regulate its NF-κB activity: a comparative study with the HTLV-1 Tax-1 protein. Retrovirology. 2012; 9:102. PMC: 3543174. DOI: 10.1186/1742-4690-9-102. View

13.

Lallemand-Breitenbach V, de The H . PML nuclear bodies. Cold Spring Harb Perspect Biol. 2010; 2(5):a000661. PMC: 2857171. DOI: 10.1101/cshperspect.a000661. View

14.

Cheng Q, Huai W, Wu X, Chen M . Sumoylation of Human Parainfluenza Virus Type 3 Phosphoprotein Correlates with A Reduction in Viral Replication. Virol Sin. 2020; 36(3):438-448. PMC: 8257846. DOI: 10.1007/s12250-020-00314-2. View

15.

Ergun S, Fernandez D, Weiss T, Li L . STING Polymer Structure Reveals Mechanisms for Activation, Hyperactivation, and Inhibition. Cell. 2019; 178(2):290-301.e10. DOI: 10.1016/j.cell.2019.05.036. View

16.

Reverter D, Lima C . Preparation of SUMO proteases and kinetic analysis using endogenous substrates. Methods Mol Biol. 2008; 497:225-39. PMC: 2771683. DOI: 10.1007/978-1-59745-566-4_15. View

17.

Mabb A, Wuerzberger-Davis S, Miyamoto S . PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol. 2006; 8(9):986-93. DOI: 10.1038/ncb1458. View

18.

Madu I, Li S, Li B, Li H, Chang T, Li Y . A Novel Class of HIV-1 Antiviral Agents Targeting HIV via a SUMOylation-Dependent Mechanism. Sci Rep. 2015; 5:17808. PMC: 4672295. DOI: 10.1038/srep17808. View

19.

Chelbi-Alix M, Thibault P . Crosstalk Between SUMO and Ubiquitin-Like Proteins: Implication for Antiviral Defense. Front Cell Dev Biol. 2021; 9:671067. PMC: 8097047. DOI: 10.3389/fcell.2021.671067. View

20.

Kim Y, Ahn J . Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus. PLoS Pathog. 2015; 11(3):e1004785. PMC: 4374831. DOI: 10.1371/journal.ppat.1004785. View